• SPX
  • $5,969.34
  • 0.35 %
  • $20.63
  • DJI
  • $44,296.51
  • 0.97 %
  • $426.16
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,003.65
  • 0.16 %
  • $31.23
OmniAb, Inc. (OABIW) Stock Price, News & Analysis

OmniAb, Inc. (OABIW) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.31

$0.02

(5.85%)

Day's range
$0.31
Day's range
$0.31
50-day range
$0.235
Day's range
$0.5799
  • Country: US
  • ISIN: US68218J1117
52 wk range
$0.31
Day's range
$0.31


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 6.39
  • Piotroski Score 2.00
  • Grade N/A
  • Symbol (OABIW)
  • Company OmniAb, Inc.
  • Price $0.31
  • Changes Percentage (5.85%)
  • Change $0.02
  • Day Low $0.31
  • Day High $0.31
  • Year High $0.31

OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) N/A
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.00
  • Trailing P/E Ratio N/A
  • Forward P/E Ratio N/A
  • P/E Growth N/A
  • Net Income $-50,619,000

Income Statement

Quarterly

Annual

Latest News of OABIW

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

OmniAb, Inc. Frequently Asked Questions

  • What is the OmniAb, Inc. stock price today?

    Today's price of OmniAb, Inc. is $0.31 — it has increased by +5.85% in the past 24 hours. Watch OmniAb, Inc. stock price performance more closely on the chart.

  • Does OmniAb, Inc. release reports?

    Yes, you can track OmniAb, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the OmniAb, Inc. stock forecast?

    Watch the OmniAb, Inc. chart and read a more detailed OmniAb, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is OmniAb, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by OmniAb, Inc. stock ticker.

  • How to buy OmniAb, Inc. stocks?

    Like other stocks, OABIW shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is OmniAb, Inc.'s EBITDA?

    OmniAb, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in OmniAb, Inc.’s financial statements.

  • What is the OmniAb, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -1.4816473481, which equates to approximately -148.16%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in OmniAb, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including OmniAb, Inc.'s financials relevant news, and technical analysis. OmniAb, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for OmniAb, Inc. stock currently indicates a “sell” signal. For more insights, review OmniAb, Inc.’s technical analysis.

  • A revenue figure for OmniAb, Inc. for its last quarter?

    OmniAb, Inc. published it's last quarterly revenues at $4.17 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.